NCT00151476 2024-09-04
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
Pfizer
Terminated
Clinical Trials
6 trialsNCT06545526 2024-08-09
Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis
Yonsei University
Phase 3 Recruiting
NCT00503035 2023-02-13
Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00585312 2021-02-21
CHIP
Pfizer
Phase 3 Terminated
NCT00033371 2020-09-29
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Completed
NCT00808743 2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3 Completed